
Nacuity Pharmaceuticals
Pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa, and stops oxidative tissue damage.
Employees
Enterprise value
$66—99m
Authorizing premium user...
Pharmaceutical company that aims to develop a breakthrough treatment for retinitis pigmentosa, and stops oxidative tissue damage.